Institute of Pathology, University Medical Center of the Johannes Gutenberg University,
Langenbeckstrasse 1, D-55101 Mainz
Germany
Research Article
Non-Equivalence of Antibiotic Generic Drugs and Risk for Intensive Care Patients
Author(s): Kirkpatrick CJ, Ramzan Rangoonwala, Mykhaylo Reshetnykov, Mike Barbeck and Shahram GhanaatiKirkpatrick CJ, Ramzan Rangoonwala, Mykhaylo Reshetnykov, Mike Barbeck and Shahram Ghanaati
Background: The underlying axiom in applying generic drugs is the equivalence of their active ingredient with the (usually more expensive) innovator product, an all-embracing statement with the insidious result that physicians assume that the generic products have been subjected to the same rigorous testing regimens as the brand-name products. The present paper presents novel experimental data on an investigator-blinded comparison between the innovator imipenem antibiotic.. Read More»
DOI:
10.4172/2167-7689.1000109
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 